A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
A legfontosabb adatok
- Hol
- Ann Arbor, Atlanta, Baltimore, Birmingham, Boston, Brooklyn, Chapel Hill, Charleston, Chicago, Cleveland, Durham, Fairborn, Greenville, Hershey, Houston, Kansas City, Lake Success, Lebanon, Louisville, Madison, Milwaukee, New Haven, New Orleans, New York, Norfolk, Philadelphia, Phoenix, Richmond, Rochester, San Francisco, Sandy Springs, St Louis, Troy, Tucson és Washington D.C. (Egyesült Államok)Mind a 35 helyszín megnézése
- Fázis
- 2/3. fázis
Helyszínek itt: Egyesült Államok
- Ann Arbor, MichiganHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Atlanta, GeorgiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Baltimore, MarylandHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Birmingham, AlabamaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Boston, MassachusettsHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Brooklyn, New YorkHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Chapel Hill, North CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Charleston, South CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Chicago, IllinoisHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Cleveland, OhioHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Durham, North CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Fairborn, OhioHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Greenville, South CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Hershey, PennsylvaniaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Houston, TexasHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Kansas City, MissouriHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Lake Success, New YorkHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Lebanon, New HampshireHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Louisville, KentuckyHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Madison, WisconsinHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Milwaukee, WisconsinHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- New Haven, ConnecticutHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- New Orleans, LouisianaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- New YorkHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Norfolk, VirginiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Philadelphia, PennsylvaniaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Phoenix, ArizonaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Richmond, VirginiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Rochester, MinnesotaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- San Francisco, CaliforniaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Sandy Springs, GeorgiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- St Louis, MissouriHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Troy, MichiganHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Tucson, ArizonaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
- Washington D.C., District of ColumbiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Priovant Therapeutics, Inc.
- Azonosító
- NCT06978725EU 2026-526437-25-00
- A regiszteradat frissítve
- 2026. november 3.
- Eredeti leírás
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.A teljes eredeti leírásKevesebb
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Cutaneous Sarcoidosis
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.
Bevonási feltételek: Adults subjects; Cutaneous sarcoidosis with characteristic skin biopsy histology; A CSAMI activity score ≥ 10; Weight > 40 kg to < 130 kg, and with a body mass index (BMI) ≤ 45 kg/m2.
Kizáró feltételek: History of cancer, with the exception of the following cancers with documentation of complete resection and no evidence of recurrence for ≥ 1 year: basal cell carcinoma, squamous cell carcinoma, or carcinoma in situ of the uterine cervix; High risk of thrombosis or cardiovascular disease; Active or recent infection; High risk of herpes zoster.